These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 34517225
1. Use of telemedicine for opioid use disorder treatment - Perceptions and experiences of opioid use disorder clinicians. Riedel L, Uscher-Pines L, Mehrotra A, Busch AB, Barnett ML, Raja P, Huskamp HA. Drug Alcohol Depend; 2021 Nov 01; 228():108999. PubMed ID: 34517225 [Abstract] [Full Text] [Related]
2. Initiating Opioid Use Disorder Medication via Telemedicine During COVID-19: Implications for Proposed Reforms to the Ryan Haight Act. Huskamp HA, Riedel L, Uscher-Pines L, Busch AB, Barnett ML, Raja P, Mehrotra A. J Gen Intern Med; 2022 Jan 01; 37(1):162-167. PubMed ID: 34713386 [Abstract] [Full Text] [Related]
3. Long-Term Prospects for Telemedicine in Opioid Use Disorder (OUD) Treatment: Results from a Longitudinal Survey of OUD Clinicians. Huskamp HA, Riedel L, Campa I, Busch AB, Rose S, Mehrotra A, Uscher-Pines L. J Gen Intern Med; 2023 Jul 01; 38(9):2139-2146. PubMed ID: 36964424 [Abstract] [Full Text] [Related]
4. Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic. Hailu R, Mehrotra A, Huskamp HA, Busch AB, Barnett ML. JAMA Netw Open; 2023 Jan 03; 6(1):e2252381. PubMed ID: 36692880 [Abstract] [Full Text] [Related]
5. Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine. Uscher-Pines L, Sousa J, Raja P, Mehrotra A, Barnett M, Huskamp HA. J Subst Abuse Treat; 2020 Nov 03; 118():108124. PubMed ID: 32893047 [Abstract] [Full Text] [Related]
6. Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives. Aronowitz SV, Engel-Rebitzer E, Dolan A, Oyekanmi K, Mandell D, Meisel Z, South E, Lowenstein M. Harm Reduct J; 2021 Nov 25; 18(1):119. PubMed ID: 34823538 [Abstract] [Full Text] [Related]
8. Patients' and Clinicians' Experiences with In-person, Video, and Phone Modalities for Opioid Use Disorder Treatment: A Qualitative Study. Wyte-Lake T, Cohen DJ, Williams S, Casey D, Chan M, Frank B, Levander XA, Stein D, White KK, Bailey SR. J Gen Intern Med; 2024 Sep 25; 39(12):2179-2186. PubMed ID: 38228990 [Abstract] [Full Text] [Related]
9. Perspectives of Patients Receiving Telemedicine Services for Opioid Use Disorder Treatment: A Qualitative Analysis of User Experiences. Sousa JL, Raja P, Huskamp HA, Mehrotra A, Busch AB, Barnett ML, Uscher-Pines L. J Addict Med; 2024 Sep 25; 16(6):702-708. PubMed ID: 35861337 [Abstract] [Full Text] [Related]
11. Use of Telehealth for Opioid Use Disorder Treatment in Safety Net Primary Care Settings: A Mixed-Methods Study. Bailey SR, Wyte-Lake T, Lucas JA, Williams S, Cantone RE, Garvey BT, Hallock-Koppelman L, Angier H, Cohen DJ. Subst Use Misuse; 2023 Sep 25; 58(9):1143-1151. PubMed ID: 37170596 [Abstract] [Full Text] [Related]
13. Many Clinicians Implement Digital Equity Strategies To Treat Opioid Use Disorder. Uscher-Pines L, Riedel LE, Mehrotra A, Rose S, Busch AB, Huskamp HA. Health Aff (Millwood); 2023 Feb 25; 42(2):182-186. PubMed ID: 36745832 [Abstract] [Full Text] [Related]
15. Implementing a low-threshold audio-only telehealth model for medication-assisted treatment of opioid use disorder at a community-based non-profit organization in Washington, D.C. Yeo EJ, Kralles H, Sternberg D, McCullough D, Nadanasabesan A, Mayo R, Akselrod H, Catalanotti J. Harm Reduct J; 2021 Dec 09; 18(1):127. PubMed ID: 34886850 [Abstract] [Full Text] [Related]
16. Exploring the use and challenges of implementing virtual visits during COVID-19 in primary care and lessons for sustained use. Mohammed HT, Hyseni L, Bui V, Gerritsen B, Fuller K, Sung J, Alarakhia M. PLoS One; 2021 Dec 09; 16(6):e0253665. PubMed ID: 34166441 [Abstract] [Full Text] [Related]
18. The intertwined expansion of telehealth and buprenorphine access from a prescriber hub. Moore DT, Wischik DL, Lazar CM, Vassallo GG, Rosen MI. Prev Med; 2021 Nov 09; 152(Pt 2):106603. PubMed ID: 33974959 [Abstract] [Full Text] [Related]